Rapport Therapeutics IPO Price Indicating $18 On 196,335 Shares; IPO Priced At $17 On 8M Shares
Portfolio Pulse from Benzinga Newsdesk
Rapport Therapeutics has set its IPO price at $17 per share for 8 million shares, with an indication of $18 per share on 196,335 shares.
June 07, 2024 | 2:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rapport Therapeutics has priced its IPO at $17 per share for 8 million shares, with an indication of $18 per share on 196,335 shares. This suggests strong initial demand and potential for a positive opening.
The IPO pricing at $17 per share and the indication of $18 per share on a smaller number of shares suggest strong initial demand. This is likely to result in a positive short-term price movement as the stock begins trading.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100